A newly published study from the University of Cambridge has found that fasting, as well as a common diabetes drug that mimics fasting, can improve myelin repair.

In the below video, our co-founder and chief science communicator, Brett Drummond, looks at and explains the findings of this study in more detail.

As always, we hope that this explanation generates conversation and discussion. If you have a question you would like to ask, please don’t hesitate to post it as a comment below or e-mail it directly to Brett at brett@mstranslate.com.au.

4 Responses

  1. Cathy D'Alterio

    WOW Brett, really interesting. Without me going back to Travis’s work what are the methods and trials he is working on and will this information alter or add to his work in remyelination? I realise that the above is still a long way from clinical trials in people but does any of the work and findings compare favourably with others working in this field?

    Reply
  2. laurie marney

    Hi Brett.
    I was lucky enough to read this a little while back. So I thought i’d ask my GP for some metformin. Well even though he says there would be no adverse affects from taking it, I couldn’t have it. So my question is ” Would it hurt”? I know your not a GP but I would like your opinion.

    Reply
    • Karen Vernon

      Hi Laurie, I see an endocrinologist who put me on Metformin as a preventative for diabetes as my family has a history. I was reluctant to take pills I don’t feel I need but after the news of remyelination, I started taking them. Maybe if you have any reason to see an endocrinologist you could ask them. I think it’s a bit out of a GPs realm to prescribe without recommendation. I also don’t know of the dosage that was used in any trials, so that makes it hard for a GP to prescribe.

      Reply

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.